Eldecalcitol | m-entrepreneurship.com

Product Name :
Eldecalcitol

Search keywords :
Eldecalcitol

drugId :
null

Target Vo:
Vitamin D receptor

Target Vo Short Name :
VDR

Moa_Name:
Vitamin D receptor agonists

First Approval Country :
Japan

First Approval Date Filter:
2011

Origin Company_Name :
Chugai Pharmaceutical Co Ltd

Active Company_Name :
Chugai Pharmaceutical Co Ltd

Active Indication_Name:
Osteoporosis, Postmenopausal

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Approved

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
FXR1 Antibody Data Sheet
JunB Rabbit mAb Cancer
phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody: phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody is an unconjugated, approximately 124 kDa, rabbit-derived, anti-phospho-LATS1+LATS2 (Thr1079 +Thr1041) polyclonal antibody. phospho-LATS1+LATS2 (Thr1079 +Thr1041) Antibody can be used for: WB, ELISA, IHC-P, IHC-F, IF expriments in human, mouse, and predicted: rat, chicken, dog, pig, cow, horse, rabbit background without labeling.

Author: Betaine hydrochloride

Related Posts